🇺🇸
United States · US · US:66215-612_7c54a125-9778-41f5-b92c-181711e22e06
UPTRAVI
Orange BookUNIISPLATC B01AC27
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerActelion Pharmaceuticals US, Inc.
CountryUS (United States)
ATC codeB01AC27
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1166215612061 BOTTLE in 1 CARTON (66215-612-06) / 60 TABLET, COATED in 1 BOTTLE
Annotations
UNII (FDA Substance ID)
5EXC0E384L
SELEXIPAG
RxCUI 1729002
Orange Book
N207947
ABABABABABABABAB
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "5EXC0E384L",
"rxcui": "1729002",
"inchikey": "QXWZQTURMXZVHJ-UHFFFAOYSA-N",
"display_name": "SELEXIPAG",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"a7a23b87-f892-4e2c-8e2e-ebf841220f90": {
"match": "brand_token",
"title": "UPTRAVI (SELEXIPAG) TABLET, COATED UPTRAVI TITRATION PACK (SELEXIPAG) KIT UPTRAVI (SELEXIPAG) INJECTION, POWDER, FOR SOLUTION UPTRAVI (SELEXIPAG) TABLET, FILM COATED [ACTELION PHARMACEUTICALS US, INC.]",
"spl_version": "26",
"published_date": "2026-06-01"
}
},
"productid": "66215-612_7c54a125-9778-41f5-b92c-181711e22e06",
"productndc": "66215-612",
"dosage_form": "TABLET, COATED",
"orange_book": {
"appl_no": "207947",
"products": [
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "0.2MG",
"product_no": "001",
"approval_date": "Dec 21, 2015"
},
{
"rs": true,
"rld": true,
"te_code": "AB",
"strength": "0.4MG",
"product_no": "002",
"approval_date": "Dec 21, 2015"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "0.6MG",
"product_no": "003",
"approval_date": "Dec 21, 2015"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "0.8MG",
"product_no": "004",
"approval_date": "Dec 21, 2015"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "1MG",
"product_no": "005",
"approval_date": "Dec 21, 2015"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "1.2MG",
"product_no": "006",
"approval_date": "Dec 21, 2015"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "1.4MG",
"product_no": "007",
"approval_date": "Dec 21, 2015"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "1.6MG",
"product_no": "008",
"approval_date": "Dec 21, 2015"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "SELEXIPAG",
"proprietary_name": "UPTRAVI",
"active_ingred_unit": "ug/1",
"application_number": "NDA207947",
"marketing_category": "NDA",
"nonproprietary_name": "Selexipag",
"start_marketing_date": "20151221",
"active_numerator_strength": "1200"
}Related drugs
Other records sharing ATC code B01AC27.
- 🇺🇸SelexipagZydus Pharmaceuticals (USA) Inc.
- 🇺🇸SelexipagZydus Lifesciences Limited
- 🇺🇸SelexipagZydus Lifesciences Limited
- 🇺🇸SelexipagZydus Lifesciences Limited
- 🇺🇸SelexipagZydus Pharmaceuticals (USA) Inc.
- 🇺🇸SelexipagZydus Pharmaceuticals (USA) Inc.
- 🇺🇸SelexipagZydus Lifesciences Limited
- 🇺🇸SelexipagZydus Pharmaceuticals (USA) Inc.
Access this data programmatically
Query UPTRAVI and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.